Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists compare two formulations of a potential asthma treatment

NCT ID NCT07712393

Not yet recruiting Knowledge-focused Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests two different versions of an experimental drug called GSK5784283 in healthy adults. The goal is to see how each formulation moves through the body and whether they work similarly. Researchers will also check for safety and side effects. The results will help decide which formulation to use in future studies for asthma.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an experimental drug called GSK5784283
What this could lead to
If successful, this study could help determine the best formulation of GSK5784283 for future asthma trials.
What could go wrong
This is an early Phase 1 study in only 24 healthy volunteers, so results may not predict effects in people with asthma. The drug may not work as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.